Cerebral Microglia Recruit Monocytes into the Brain in Response to Tumor Necrosis Factorα Signaling during Peripheral Organ Inflammation
暂无分享,去创建一个
M. Swain | C. D’Mello | T. Le
[1] N. Van Rooijen,et al. Ly6c+ “inflammatory monocytes” are microglial precursors recruited in a pathogenic manner in West Nile virus encephalitis , 2008, The Journal of experimental medicine.
[2] R. Dantzer,et al. Tumor necrosis factor-α-induced sickness behavior is impaired by central administration of an inhibitor of c-jun N-terminal kinase , 2008, Psychopharmacology.
[3] S. Rivest,et al. MyD88 signaling in brain endothelial cells is essential for the neuronal activity and glucocorticoid release during systemic inflammation , 2008, Molecular Psychiatry.
[4] E. Masliah,et al. Neurobiology of HIV , 2008, International review of psychiatry.
[5] A. Mildner,et al. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions , 2007, Nature Neuroscience.
[6] W. Rostène,et al. Chemokines: a new class of neuromodulator? , 2007, Nature Reviews Neuroscience.
[7] R. Dantzer,et al. TNFα-induced sickness behavior in mice with functional 55 kD TNF receptors is blocked by central IGF-I , 2007, Journal of Neuroimmunology.
[8] D. Dickson,et al. Actin-binding Proteins Coronin-1a and IBA-1 are Effective Microglial Markers for Immunohistochemistry , 2007, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[9] C. Zwingmann,et al. Endotoxemia produces coma and brain swelling in bile duct ligated rats , 2007, Hepatology.
[10] F. Crews,et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration , 2007, Glia.
[11] M. Odeh. Pathogenesis of hepatic encephalopathy: the tumour necrosis factor‐α theory , 2007, European journal of clinical investigation.
[12] J. O'Callaghan,et al. Divergent Roles for Tumor Necrosis Factor-α in the Brain , 2007, Journal of Neuroimmune Pharmacology.
[13] S. Hopkins. Central nervous system recognition of peripheral inflammation: a neural, hormonal collaboration. , 2007, Acta bio-medica : Atenei Parmensis.
[14] S. Rivest,et al. Role of IL-1 and TNF in the brain: Twenty years of progress on a Dr. Jekyll/Mr. Hyde duality of the innate immune system , 2007, Brain, Behavior, and Immunity.
[15] F. Tacke,et al. Migratory fate and differentiation of blood monocyte subsets. , 2006, Immunobiology.
[16] V. Pérez-Alvarez,et al. Chronic bile duct obstruction induces changes in plasma and hepatic levels of cytokines and nitric oxide in the rat. , 2006, Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie.
[17] S. Gold,et al. Depression and immunity: inflammation and depressive symptoms in multiple sclerosis. , 2006, Neurologic clinics.
[18] R. Dantzer. Cytokine, sickness behavior, and depression. , 2006, Neurologic clinics.
[19] Thomas Christen,et al. Connexin37 protects against atherosclerosis by regulating monocyte adhesion , 2006, Nature Medicine.
[20] M-A Mayoux-Benhamou. Fatigue and rheumatoid arthritis. , 2006, Annales de readaptation et de medecine physique : revue scientifique de la Societe francaise de reeducation fonctionnelle de readaptation et de medecine physique.
[21] R. Duman,et al. TNFα Signaling in Depression and Anxiety: Behavioral Consequences of Individual Receptor Targeting , 2006, Biological Psychiatry.
[22] R. Klein,et al. A tumor necrosis factor receptor 1-dependent conversation between central nervous system-specific T cells and the central nervous system is required for inflammatory infiltration of the spinal cord. , 2006, The American journal of pathology.
[23] T. Möller,et al. Microglia Biology in Health and Disease , 2006, Journal of Neuroimmune Pharmacology.
[24] M. Swain. Fatigue in liver disease: pathophysiology and clinical management. , 2006, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[25] R. Ransohoff,et al. The many roles of chemokines and chemokine receptors in inflammation. , 2006, The New England journal of medicine.
[26] A. Gottlieb,et al. Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial , 2006, The Lancet.
[27] P. Kubes,et al. TNF‐α–secreting monocytes are recruited into the brain of cholestatic mice , 2006 .
[28] S. Gold,et al. Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour? , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[29] S. Gordon,et al. Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.
[30] R. Dantzer,et al. Inhibition of vagally mediated immune-to-brain signaling by vanadyl sulfate speeds recovery from sickness. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[31] A. A. Romanovsky,et al. Fever and hypothermia in systemic inflammation: recent discoveries and revisions. , 2005, Frontiers in bioscience : a journal and virtual library.
[32] Ansuman T. Satpathy,et al. IL-1β-Mediated Innate Immunity Is Amplified in the db/db Mouse Model of Type 2 Diabetes1 , 2005, The Journal of Immunology.
[33] S. Sarin,et al. Beneficial Effects of Tumor Necrosis Factor-α Inhibition by Pentoxifylline on Clinical, Biochemical, and Metabolic Parameters of Patients with Nonalcoholic Steatohepatitis , 2004, American Journal of Gastroenterology.
[34] Shigeo Kobayashi,et al. Signaling the brain in inflammation: the role of endothelial cells. , 2004, Frontiers in bioscience : a journal and virtual library.
[35] A. Masuda,et al. Kupffer cell–derived interleukin 10 is responsible for impaired bacterial clearance in bile duct–ligated mice , 2004, Hepatology.
[36] P. Lipsky,et al. Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate. , 2004, Arthritis and rheumatism.
[37] S. Cepok,et al. Multiple sclerosis -- a coordinated immune attack across the blood brain barrier. , 2004, Current neurovascular research.
[38] S. Kunkel,et al. Alterations in cytokine/chemokine expression during organ-to-organ communication established via acetaminophen-induced toxicity. , 2003, Experimental and molecular pathology.
[39] B. Aggarwal. Signalling pathways of the TNF superfamily: a double-edged sword , 2003, Nature Reviews Immunology.
[40] G. Davies-Jones,et al. Cytokine regulation of MCP-1 expression in brain and retinal microvascular endothelial cells , 2003, Journal of Neuroimmunology.
[41] W. Kuziel,et al. Chemokine Expression by Glial Cells Directs Leukocytes to Sites of Axonal Injury in the CNS , 2003, The Journal of Neuroscience.
[42] Steffen Jung,et al. Blood monocytes consist of two principal subsets with distinct migratory properties. , 2003, Immunity.
[43] Y. Pollak,et al. The EAE-associated behavioral syndrome I. Temporal correlation with inflammatory mediators , 2003, Journal of Neuroimmunology.
[44] Y. Pollak,et al. The EAE-associated behavioral syndrome II. Modulation by anti-inflammatory treatments , 2003, Journal of Neuroimmunology.
[45] R. Ransohoff,et al. The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). , 2003, Seminars in immunology.
[46] D. Gouma,et al. Endogenous interferon γ protects against cholestatic liver injury in mice , 2002 .
[47] B. Rovin,et al. HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[48] M. Bala,et al. Infliximab Improves Quality of Life in Patients with Crohn's Disease , 2002, Inflammatory bowel diseases.
[49] R. Tandon,et al. Fatigue in cholestatic liver disease—a perplexing symptom , 2002, Postgraduate medical journal.
[50] W. Rostène,et al. Distribution, cellular localization and functional role of CCR2 chemokine receptors in adult rat brain , 2002, Journal of neurochemistry.
[51] M. Swain,et al. Increased sensitivity to the locomotor-activating effects of corticotropin-releasing hormone in cholestatic rats. , 2002, Gastroenterology.
[52] G. Tarozzo,et al. Flow Cytometric Analysis of Inflammatory Cells in Ischemic Rat Brain , 2002, Stroke.
[53] J. Clements,et al. Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis. , 2001, The Journal of infectious diseases.
[54] L. Koniaris,et al. Cytokine-Responsive Gene-2/IFN-Inducible Protein-10 Expression in Multiple Models of Liver and Bile Duct Injury Suggests a Role in Tissue Regeneration1 , 2001, The Journal of Immunology.
[55] S. Rivest,et al. Regulation of the gene encoding the monocyte chemoattractant protein 1 (MCP‐1) in the mouse and rat brain in response to circulating LPS and proinflammatory cytokines , 2001, The Journal of comparative neurology.
[56] B. Rollins,et al. Absence of Monocyte Chemoattractant Protein 1 in Mice Leads to Decreased Local Macrophage Recruitment and Antigen-Specific T Helper Cell Type 1 Immune Response in Experimental Autoimmune Encephalomyelitis , 2001, The Journal of experimental medicine.
[57] M. Swain,et al. Increased midbrain 5-HT1A receptor number and responsiveness in cholestatic rats , 2001, Brain Research.
[58] R. Dantzer,et al. Role of interleukin‐1β and tumour necrosis factor‐α in lipopolysaccharide‐induced sickness behaviour: a study with interleukin‐1 type I receptor‐deficient mice , 2000 .
[59] H. Weiner,et al. Resistance to Experimental Autoimmune Encephalomyelitis in Mice Lacking the Cc Chemokine Receptor (Ccr2) , 2000, The Journal of experimental medicine.
[60] K. Frei,et al. TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease. , 2000, Brain : a journal of neurology.
[61] A. Kilbourne,et al. The impact of irritable bowel syndrome on health-related quality of life. , 2000, Gastroenterology.
[62] Q. Pittman,et al. Attenuated febrile response to lipopolysaccharide in rats with biliary obstruction. , 2000, American journal of physiology. Gastrointestinal and liver physiology.
[63] R. Dantzer,et al. Increased Sensitivity of Prediabetic Nonobese Diabetic Mouse to the Behavioral Effects of IL-1 , 1999, Brain, Behavior, and Immunity.
[64] S. Rivest,et al. Effects of circulating tumor necrosis factor on the neuronal activity and expression of the genes encoding the tumor necrosis factor receptors (p55 and p75) in the rat brain: a view from the blood–brain barrier , 1999, Neuroscience.
[65] H. Anisman,et al. Sensitization to the Effects of Tumor Necrosis Factor-α: Neuroendocrine, Central Monoamine, and Behavioral Variations , 1999, The Journal of Neuroscience.
[66] K. Rioux,et al. Augmented interleukin‐1β–induced depression of locomotor activity in cholestatic rats , 1998, Hepatology.
[67] M. Swain,et al. Chronic cholestasis in rats induces anhedonia and a loss of social interest , 1998, Hepatology.
[68] M. Swain,et al. Improvement in cholestasis‐associated fatigue with a serotonin receptor agonist using a novel rat model of fatigue assessment , 1997, Hepatology.
[69] M. Burdick,et al. Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. , 1996, Journal of immunology.
[70] D. Gouma,et al. Increased concentrations of tumour necrosis factor (TNF) and soluble TNF receptors in biliary obstruction in mice; soluble TNF receptors as prognostic factors for mortality. , 1996, Gut.
[71] M. Swain,et al. Defective corticotropin‐releasing hormone mediated neuroendocrine and behavioral responses in cholestatic rats: Implications for cholestatic liver disease–related sickness behaviors , 1995, Hepatology.
[72] M. Swain,et al. Suppression of hypothalamic-pituitary-adrenal axis responsiveness to stress in a rat model of acute cholestasis. , 1993, The Journal of clinical investigation.
[73] R. Dantzer,et al. From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.
[74] ScienceDirect. Annales de réadaptation et de médecine physique , 2008 .
[75] R. Dantzer,et al. Named Series: Twenty Years of Brain, Behavior, and Immunity Twenty years of research on cytokine-induced sickness behavior , 2007 .
[76] R. Ransohoff,et al. The expression and function of chemokines involved in CNS inflammation. , 2006, Trends in pharmacological sciences.
[77] B. Barna,et al. Elevated monocyte chemotactic proteins 1, 2, and 3 in pulmonary alveolar proteinosis are associated with chemokine receptor suppression. , 2005, Clinical immunology.
[78] T. Kielian. Microglia and chemokines in infectious diseases of the nervous system: views and reviews. , 2004, Frontiers in bioscience : a journal and virtual library.